California State Teachers Retirement System (CalSTRS)
NVCT icon

California State Teachers Retirement System (CalSTRS)’s Nuvectis Pharma NVCT Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.99K Sell
217
-620
-74% -$6.94K ﹤0.01% 2631
2026
Q1 		$6.47K Sell
837
-116
-12% -$994 ﹤0.01% 2812
2025
Q4 		$7.2K Buy
953
+149
+19% +$971 ﹤0.01% 2885
2025
Q3 		$4.84K Buy
804
+1
+0.1% +$7 ﹤0.01% 2984
2025
Q2 		$6K Buy
+803
New +$7.28K ﹤0.01% 2882
2024
Q2 		– Sell
-747
Closed -$6.13K – 3155
2024
Q1 		$6.13K Sell
747
-477
-39% -$4.06K ﹤0.01% 2984
2023
Q4 		$10.2K Sell
1,224
-417
-25% -$3.72K ﹤0.01% 2999
2023
Q3 		$21.2K Sell
1,641
-638
-28% -$9.24K ﹤0.01% 2975
2023
Q2 		$36.4K Buy
+2,279
New +$36.4K ﹤0.01% 3007

Other funds holding NVCT

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $193M AUM 233.09% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s NVCT Position: Q2 2026 in Review

California State Teachers Retirement System (CalSTRS) reduced its Nuvectis Pharma (NVCT) stake by 74% in Q2 2026, selling an estimated $6.94K and leaving 217 shares worth $3.99K. The position accounts for ﹤0.01% of the portfolio, ranked #2631.

California State Teachers Retirement System (CalSTRS) first reported a position in NVCT in Q2 2023 and has held it in 9 quarters since. The position peaked at $36.4K in Q2 2023. 82 funds tracked by Wall St. Rank hold NVCT as of Q2 2026.

  • California State Teachers Retirement System (CalSTRS) held 217 shares of Nuvectis Pharma worth $3.99K as of Q2 2026.
  • California State Teachers Retirement System (CalSTRS) sold 620 Nuvectis Pharma shares in Q2 2026, an estimated $6.94K.
  • Nuvectis Pharma made up ﹤0.01% of California State Teachers Retirement System (CalSTRS)'s portfolio in Q2 2026, its #2631 holding.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Nuvectis Pharma in Q2 2023 and has held it in 9 quarters since.
  • California State Teachers Retirement System (CalSTRS)'s Nuvectis Pharma position peaked at $36.4K in Q2 2023.
  • 82 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q2 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q2 2026, filed 24 Aug 2026.